BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to
provide a survival benefit in patients with resected stage I nonsmall cell lung cancer …

PURPOSE The aim of this study is to present an analysis investigating the association of
patient characteristics with overall survival (OS) in individuals with stage III non–small-cell …

Background: The role of histology in the targeted management of nonsmall cell lung cancer
(NSCLC) has garnered renewed attention in recent years. We provide contemporary …

The duration of survival in early-stage lung cancer (stages I and II) varies between reports in
the literature. Several reasons account for this: patient population heterogeneity …

Objectives The purpose of this study was to evaluate risk factors for tumor recurrence in
patients with completely resected early-stage non-small cell lung cancer (NSCLC). Methods …

Background Although there has been a significant survival improvement for patients with
metastatic NSCLC enrolled in randomized trials, it is not clear whether a similar benefit is …

Objective: This study investigated the factors predicting recurrence and death in patients
with resected stage-I non–small-cell lung cancers according to the 7th edition of tumor …

OBJECTIVE: Using a national cancer registry, we determined the postoperative survival of
patients with stage IA non–small cell lung cancer in the United States from 1988 to 1997 and …

OBJECTIVE: Our objective was to determine whether histologic grade independently
contributes to the prognosis of non–small cell lung cancer. METHODS: A total of 5018 …

Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of
patients with differences in the extent and localization of disease. Many aspects of stage III …